resistance to antiangiogenic therapy in lung cancer
Published 7 years ago • 477 plays • Length 5:29Download video MP4
Download video MP3
Similar videos
-
3:00
nsclc: mechanisms of resistance to antiangiogenic therapy
-
5:29
mechanisms of anti-angiogenic therapy in lung cancer
-
6:01
future directions for antiangiogenic therapy in lung cancer
-
3:47
antiangiogenic resistance in mrcc
-
2:02
dr. goldberg discusses resistance to egfr tki therapy in nsclc
-
3:05
rationale behind antiangiogenic therapy in nsclc
-
5:43
antiangiogenic therapy in advanced nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
0:43
dr. jackman on overcoming resistance to egfr inhibitors in lung cancer
-
1:02
dr. socinski on mechanisms of resistance in lung cancer
-
1:41
guk1 as a driver of resistance to targeted therapies in lung cancer
-
6:03
managing resistance to egfr tkis in nsclc
-
6:11
how does antiangiogenic therapy work?
-
2:48
targeted therapy resistance mechanisms in alk nsclc
-
1:23
mechanisms resulting in resistance to checkpoint inhibitors in nsclc
-
3:02
using antiangiogenic therapy in stage 4 nsclc
-
9:12
the current role for antiangiogenic therapy for nsclc
-
0:55
dr. reimuth discusses studies looking at resistance to egfr tkis in nsclc
-
3:00
egfr-resistant disease in lung cancer